The litigation further alleges that pharmaceutical manufacturers continued aggressively marketing GLP-1 medications despite growing concerns surrounding delayed gastric emptying, intestinal motility disorders, and reported optic nerve injuries
Glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes: differences and similarities
Future PCOS-specific economic studies should model not only weight and metabolic effects, but also fertility timing, washout-related delay, ART utilization, and potential rebound-related costs
The GLP-1 receptor agonists, exenatide and liraglutide, mimic the action of endogenous GLP-1
If a person has too little GLP-1, this may lead to a person eating more during meals or snacking between meals
You can stay on GLP-1 medications long-term